Comparison

EBMcalc Complete vs myFibroScan

Price, ratings, monetisation and update history for both apps, side by side — with what reviewers say about each.

Head to head
About

EBMcalc Complete

This comprehensive medical calculator system offers over 720 tools, including formulae, clinical criteria sets, and dose converters. It aids clinicians, educators, nurses, and students in applying Evidence-Based Medicine principles with a vast array of daily-use resources.

Highlights
  • Over 720 medical formulae
  • Clinical criteria sets
  • Dose and unit converters
  • Statistical models
  • Embedded data tables
  • Decision tree tools
Features
Read full description

EBMcalc Complete EBMcalc is the most popular and comprehensive Medical Calculator system on the web. EBMcalc has been highly acclaimed, reviewed and tested over the last 25 years. As a trusted resource it has been integrated into many prestigious websites for Medical Education, Medical Literature, Pharmacology, Nursing and more. Now you can put this invaluable resource in the palm of your hand! EBMcalc users should not make any medical decisions based on app content without seeking their doctor's advice. EBMcalc encompasses over 720 pertinent medical formulae, clinical criteria sets, decision tree tools and dose/unit converters used every day by clinicians, educators, nurses, pharmacologists and students of all types. With the growing emphasis on Evidence-Based Medicine, there has never been a greater need for a system such as EBMcalc. EBMcalc Complete Edition mirrors the web based resource http://EBMcalc.com There you can see the complete list of components you’ll have in the iPhone Edition: There are hundreds of basic calculators and unit/dose converters such as: A-a Gradient Anion Gap “Delta-Delta” Adult and pediatric Creat Clearance and GFR calculators Adult Body Mass Index Burn Injury Fluid Resuscitation (Parkland) Cardiac Output Corticosteroid Medication Dosing Conversions Estimated Date of Delivery Pregnancy Calculator Kappa Measurement of Inter-observer Agreement MELD, MELD-Na and PELD Scores Number Needed to Treat/Harm Opioid Medication Dose Conversions Oxygen Delivery Units Conversions PFT Predicted Values (multiple) Peak Expiratory Flow Prediction Pharmacokinetcs calculators SI Unit Conversions: Body Fluid Chemistries Standard Drink Equivalents Water Deficit in Hypernatremia You also get very complex calculators that utilize statistical models and embedded data tables. Calculators such as: Acetaminophen Toxicity Assessment Blood Pressure Percentiles in Children Body Mass Index Percentiles in Children Height for Age Percentiles for Boys Multiple other Pediatric Growth Assessment calculators There are also Hundreds of Clinical Criteria Sets and Decision Tree modules such as: Apgar Score Asthma Hospitalization One Year Risk TreeCalc Behcet's Syndrome International Study Group Criteria BODE Index for COPD Survival Prediction Cardiac Risk Assessments including Framingham studies CHADS-2 Diabetes Type Predictor DVT and PE predictor models Ectopic Pregnancy Risk Estimation Endocarditis Diagnostic Criteria Gail Models for Breast Cancer Risk Assessment Hepatitis scoring systems Influenza Diagnosis and Treatment Jones Criteria Metabolic Syndrome Criteria (multiple) Mycoplasma Pneumoniae Prediction Neurofibomatosis Type 2 Diagnostic Criteria Newborn Hyperbilirubinemia Assessment NIH Stroke Score Ottawa and Pittsburgh Orthopedic Rules Perioperative Cardiac Evaluation Pneumonia morbidity and mortality predictors (multiple) Renal Artery Stenosis Prediction Model. Stroke Risk in Patients 55-84 Years Old (Framingham data) Exploring EBMcalc by Specialty reveals the extensive knowledge base and literature review presented in EBMcalc. Specialty indexes include: Anesthesia Anthropometrics Cardiology Critical Care Dermatology Emergency Medicine Endocrinology Epidemiology Gastroenterology Geriatrics Hematology Infectious Disease Medical Education Medical Statistics Nephrology Neurology Nursing Nutrition Oncology Orthopedics Pain Management Pediatrics Pharmacology Physical Medicine & Rehabilitation Psychiatry Pulmonology Rheumatology Smoking Cessation Surgery Women's Health Workers' Compensation To practice, teach and learn medicine based on solid, literature based evidence, EBMcalc provides easy to use, interactive tools for your Evidence-Based Medicine.

About

myFibroScan

This app assists healthcare professionals in interpreting FibroScan® results for liver health management. It provides tools and scores based on clinical studies to aid in assessing liver disease and identifying at-risk patients.

Highlights
  • Interpretation Guide for FibroScan® results
  • FibroScan® based scores for liver disease assessment
  • Fast score for MASH patient risk identification
  • Agile 3+ score for advanced fibrosis identification
  • Agile 4 score for cirrhosis identification
  • MASH Treatment Eligibility Tool
Features
Read full description

FibroScan® is the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is powered by three unique, patented and validated biomarkers, LSM by VCTE™ (Liver Stiffness Measurement) and CAP™ (Controlled Attenuation Parameter) that benefit from a worldwide clinical evidence with over 5300+ peer-reviewed publications and 180+ international guidelines. myFibroScan app is your everyday FibroScan® companion to access Interpretation Guide and FibroScan® based scores in an easy, fast and intuitive way : The Interpretation Guide utilizes data from clinical studies to assist providers in interpreting FibroScan® examination results. Scores enhance FibroScan® liver disease assessment with biological markers. Scores are presented as educational services intended for licensed healthcare professionals. While the scores are about specific medical and healthcare issues, they are not a substitute for/or replacement of personalized medical advice and are not intended to be used as the sole basis for making individualized medical or health-related decisions. • Fast is an aid to identify at risk MASH patients defined as MASH + NAS≥4 + F≥2. Good to excellent performance in cohorts from different clinical settings (MASLD tertiary care unit, screening, bariatric surgery) and geographical origins (USA, Europe, Asia). Several publications advocate the use of Fast. • Agile 3+ is an aid to identify MASLD patients with advanced fibrosis by combining LSM by VCTE™ and routine clinical parameters to reduce the need for liver biopsy. High clinical performances are demonstrated in large external validation cohorts from different geographical origins. • Agile 4 is an aid to early identify MASLD patients with cirrhosis by combining LSM by VCTE™ and routine clinical parameters. It can help the physicians to manage the disease to prevent liver-related complications such as hepatocellular carcinoma. High clinical performances are demonstrated in large external validation cohorts from different geographical origin. MASH Treatment Eligibility Tool to eliminate the Guesswork. This patient management tool embeds treatment recommendations based on the patient’s FibroScan® results and the latest AASLD Guidance.

Screenshots

EBMcalc Complete4 screens
myFibroScan4 screens

Verdict

The call

EBMcalc Complete and myFibroScan both sit at 3.0 stars, but that hides the real split: 50% of EBMcalc Complete's written reviews are positive against 0% of myFibroScan's. EBMcalc Complete also leads on iOS requirement (10.0 vs 15.6). myFibroScan's advantage is price (Free vs $9.99). On rating, ratings volume, update cadence and ads there is nothing between them.

Scored on Price · Rating · Positive reviews · Number of ratings · Update frequency · Ads · In-app purchases · Monetization · Best chart rank · Devices · Requires iOS

CostPrice · In-app purchases · Ads · Monetization

myFibroScan is free to download; EBMcalc Complete costs $9.99 up front. Neither carries in-app purchases, so what you see is what you pay.

ReceptionRating · Positive reviews · Number of ratings

On the App Store both sit at effectively the same score — 3.0 for EBMcalc Complete against 3.0 for myFibroScan. Both are backed by a comparable volume of ratings — 3 and 4 respectively. Written reviews are what separate them: 50% of EBMcalc Complete's written reviews are positive against 0% of myFibroScan's.

UpkeepUpdate frequency

EBMcalc Complete ships an update every 6 months, myFibroScan every 8 months. The most recent releases landed on September 12, 2026 and September 16, 2026 respectively.

Scorecard4 real differences · 6 level
EBMcalc Complete versus myFibroScan: the parameters behind the verdict, then further details
ParameterEBMcalc CompletemyFibroScan
Price$9.99Free — better
Rating3.0 (3 ratings)3.0 (4 ratings)
Positive reviews50.0% of reviews — better0.0% of reviews
Number of ratings34 — better
Update frequencyEvery 6 months — betterEvery 8 months
AdsNoNo
In-app purchasesNoNo
MonetizationPaidAd-supported — better
DevicesiPhone, iPad, iPodiPhone, iPad, iPod
Requires iOS10.0 — better15.6
Further details — not scored
Size21 MB40 MB
Age rating12+17+
DeveloperFoundation Internet Services, LLCECHOSENS

Customer experience

EBMcalc Complete

All ratings3 ratings
Positive33.3%
Neutral33.3%
Negative33.3%
Written reviews8 reviews
Positive50.0%
Neutral37.5%
Negative12.5%

myFibroScan

All ratings4 ratings
Positive50.0%
Neutral0.0%
Negative50.0%
Written reviews6 reviews
Positive0.0%
Neutral16.7%
Negative83.3%

In-app purchases

None

EBMcalc Complete

No in-app purchases

None

myFibroScan

No in-app purchases

Questions

Is EBMcalc Complete free?
EBMcalc Complete costs $9.99, with no in-app purchases.
Is myFibroScan free?
myFibroScan is free to download, with no in-app purchases.
Which has better reviews, EBMcalc Complete or myFibroScan?
EBMcalc Complete and myFibroScan are both rated 3.0 out of 5 on the App Store, from 3 and 4 ratings respectively.
Do EBMcalc Complete or myFibroScan have ads?
Neither EBMcalc Complete nor myFibroScan shows ads.
Which is updated more often, EBMcalc Complete or myFibroScan?
EBMcalc Complete ships an update every 6 months, and myFibroScan every 8 months. Most recently, EBMcalc Complete was updated on September 12, 2026 and myFibroScan on September 16, 2026.

Other comparisons